Headline speaker named for high-profile Pharma Integrates event
High-profile industry leaders set to discuss key topics, issues and advances in the drug development and supply sector.
A former Chief Executive at Roche Pharmaceuticals, William (Bill) Burns, has been confirmed as event chair for a popular 2-day life sciences conference that is set to sell-out for the fourth year in a row.
Pharma Integrates is taking place on 17–18 November at the Grange City Hotel, London and will once again see a number of high-profile industry leaders discuss key topics, issues and advances in the drug development and supply sector.
Organised by Life Sciences Index, the event will see more than 70 speakers and moderators alongside a further 250 senior executives attending from a range of global pharmaceutical and biotechnology firms, including AstraZeneca, GSK, Pfizer, Sanofi and Takeda Pharmaceuticals.
Burns has worked within life science organisations for his entire career and retired from Roche Pharmaceuticals in 2014. He now serves on the board of five healthcare companies and advises panels such as the Institute of Cancer Research in London.
He said: “I am honoured and very much looking forward to being the headline speaker at this year’s Pharma Integrates. The major theme this year is about integration, which is a pivotal issue in our industry right now.
“Other agenda items at the conference will include breakthrough content and what this means for the sector. Business models, supply chain issues, outsourcing, funding and Pharmergence are also key talking points.
“There are a number of well-known and respected leaders with interesting backgrounds speaking this year, which will allow life science executives to stay current and connect even further with the industry.”
Aside from speakers, the 2-day conference sponsored by the companies such as Catalent Pharma Solutions, Pfizer and Patheon, encompasses an online networking tool to facilitate meetings, a supplier exhibition, panel discussions and Q&A sessions with some of the biggest names in the industry.
Samuel Thangiah, co-founder at Life Sciences Index, said: “We’re looking forward to the 2015 conference and we have worked hard to organise an exciting agenda to surpass last year’s event.
“This year will also see an influx of emerging biotechnology companies that will join those from Big Pharma, speciality pharmaceutical and the contract services sector, so it will make for an exciting conference with great networking opportunities.
“We are proud that we are now championing the global pharmaceutical industry right here in London every year, which is allowing leaders to debate key topics that shape pharma’s future.”
Life Sciences Index launched in 2011 and is a specialist provider of events designed for pharmaceutical executives to network, stay current on topical issues and provides continuous professional development.
Related News
-
News CPHI Frankfurt: Interview with Marcelo Cruz, Vice President, Business Development & Marketing at Tjoapack
In this series of interviews, we caught up with some of the exhibitors at CPHI Frankfurt to discover what innovations are being brought to the pharmaceutical industry this year. Here we chat with Marcelo Cruz of Tjoapack to discuss how global events ar... -
News CPHI Frankfurt 2022: Innovator Interviews – Bioiberica
In this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We caught up with Mónica Gómez Navarro (Marketing Manager Branded Ingredients), ... -
News CPHI Frankfurt 2022: Innovator Interview – Procaps Group
In this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We interviewed Rosella Del Vecchio Herrera, Marketing Director at Procaps Group, to discover h... -
News From the floor - CPHI Frankfurt 2022
The live blog from the people on the ground at CPHI Frankfurt - covering all stand-out news, memorable moments, and keynote updates from the 2022 event. -
News How to Commercialise an Advanced Therapy: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Andrea Zobel, Senior Director, Personalized Supply Chain at World Courier (Berlin Germany), Melissa Lattanzi, VP Emerging Therapies at AmerisourceBergen (King of Prussia, USA), and Hans-Peter Scherzer, Customer Suc... -
News CDMO - Health is a Joint Project: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Emanuele Agnese, Business Development Manager and Pietro Allegrini, R&D Director at Indena, present the ways in which a reliable manufacturing partner in the pursuit of better health outcomes for patients and pharm... -
News Streamlined Development for Efficient Production of Bispecific Molecules: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Séverine Fagète, VP, Cell Line Development Services at Selexis (Geneva, Switzerland), and Brandon Brino (Durham, USA), Process Development Scientist and Group Leader at KBI Biopharma, present an overv... -
News MDR – How to collect post-market clinical follow-up data (PMCF): Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Philipp Annecke, Junior Key Account Manager and Heinrich Martens, VP Regulatory Affairs of Fresenius Kabi (Bad Homburg, Germany) present guidances from the Medical Devices Regulation on clinical data evaluatio...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance